Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Clinical trial NCT00402025 · COMPLETED

Trial details

NCT number: NCT00402025
Sponsor: BioVex Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2006-11-01
Primary completion: 2008-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.